2024 annual financial data
MapLight Therapeutics 2024 Operating margin
MapLight Therapeutics 2024 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -82,946,000 USD and net income was -77,580,000 USD.
Operating cash flow was -78,815,000 USD.
Get free MapLight Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- Not available
- Operating income
- -82,946,000 USD
- Net income
- -77,580,000 USD
- Operating cash flow
- -78,815,000 USD